Sanara Medtech Inc
NASDAQ:SMTI
Sanara Medtech Inc
Cash from Financing Activities
Sanara Medtech Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sanara Medtech Inc
NASDAQ:SMTI
|
Cash from Financing Activities
$9.6m
|
CAGR 3-Years
150%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
18%
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Financing Activities
$100.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Financing Activities
$116m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Financing Activities
-$307m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Financing Activities
-$598.3m
|
CAGR 3-Years
-169%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-32%
|
See Also
What is Sanara Medtech Inc's Cash from Financing Activities?
Cash from Financing Activities
9.6m
USD
Based on the financial report for Dec 31, 2023, Sanara Medtech Inc's Cash from Financing Activities amounts to 9.6m USD.
What is Sanara Medtech Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
18%
The average annual Cash from Financing Activities growth rates for Sanara Medtech Inc have been 150% over the past three years , and 18% over the past ten years .